(Q35561464)

English

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

scientific article published on 12 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

Georg A. Bjarnason

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Martin Smoragiewicz

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ravindran Kanesvaran

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ulka Vaishampayan

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Toni K Choueiri

19

object named as

Toni K Choueiri

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Jenny J Ko

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Wanling Xie

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nils Kroeger

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jae-Lyun Lee

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Brian I Rini

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jennifer J Knox

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sandy Srinivas

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sumanta K Pal

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Takeshi Yuasa

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Lori Wood

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

D Scott Ernst

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Neeraj Agarwal

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Daniel Y C Heng

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

12 February 2015

1 reference

Europe PubMed Central

8 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

293-300

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression modelling strategies for improved prognostic prediction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

'Would you like to talk about your future treatment options'? Discussing the transition from curative cancer treatment to palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971222-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)71222-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25681967%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35561464&oldid=1579516622"